✦ LIBER ✦

Pharmacokinetic—pharmacodynamic interaction between nebicapone and controlled-release levodopa/benserazide: A single-center, phase I, double-blind, randomized, placebo-controlled, four-way crossover study in healthy subjects

✍ Scribed by Teresa Nunes; Rita Machado; José F. Rocha; Carlos Fernandes-Lopes; Raquel Costa; Leonel Torrão; Ana I. Loureiro; Amílcar Falcão; Manuel Vaz-da-Silva; Lyndon Wright; Luis Almeida; Patricio Soares-da-Silva

Book ID: 113544073
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 287 KB
Volume: 31
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2009.10.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two single-center, double-blind, randomi

Two single-center, double-blind, randomized, placebo-controlled, phase i studies to investigate the tolerability and pharmacokinetics of ch-1504, an antifolate, in healthy male subjects

✍ Tim Mant; Stipo Jurcevic; Cameron Szakacs; Luthando Adams; John Boland; Lawrence 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 193 KB

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND,

737 A PHASE-I, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SINGLE ESCALATING ORAL DOSES OF GS-9620 IN HEALTHY SUBJECTS

✍ U. Lopatin; G. Wolfgang; R. Kimberlin; D. Turnas; M. Cornprost; G. Chittick; C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Pharmacokinetics, pharmacodynamics, and

Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: A dose—block-randomized, double-blind, placebo-controlled, ascending single-dose, phase I study

✍ Kyoung Soo Lim; Jung-Ryul Kim; Yun-Jung Choi; Kwang-Hee Shin; Kyu-Pyo Kim; Jang- 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 169 KB